e-Drug3D

996

AMPHOTERICIN B


INN
AMPHOTERICIN B

cas 1397-89-3
CLASS

ANTIINFECTIVES
ANTIFUNGAL
AMEBICIDES
ANTI-BACTERIAL AGENTS
ANTIPROTOZOAL AGENTS
PRODUCED FROM A STRAIN OF STREPTOMYCES NODOSUS
HIGH AFFINITY FOR THE ERGOSTEROL COMPONENT OF THE FUNGAL CELL MEMBRANE

ROUTE (list)

TOPICAL ORAL INJECTION

ATC code

J02AA01
A01AB04
A07AA07
G01AA03

PK parameters

VD 6.5 LITER (65 KILOGRAM)
Cl 0.715 LITER / HOUR (65 KILOGRAM)
PPB 90 PERCENT
t1/2 8.5 HOUR

Target

TARGET MEMBRANE

PDB
7SHI (CRYSTAL STRUCTURE OF CYTOCHROME P450 AMPHL FROM STREPTOMYCES NODOSUS AND THE STRUCTURAL BASIS FOR SUBSTRATE SELECTIVITY IN MACROLIDE METABOLIZING P450S)

Ligand code = 4UH (link to the list of PDB complexes)

Download experimental 3D coordinates of 4UH with added hydrogens

DrugCentral

Unknown

Download SDF file (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid

Formula:
C47H73NO17

Calculated chemical properties:

MW 923.06
NB_atoms 65
XLogP -0.62
PSA 290.719
NB_HD 12
NB_HA 18
fsp3 0.66
Lipinski(0=no;1=yes) 0

FDA
NDA 060570 (pdf not found) INN (AMPHOTERICIN B) FUNGIZONE (APOTHECON) APPROVAL= AP YEAR= 1964 DISCONTINUED
NDA 050313 (pdf not found) INN (AMPHOTERICIN B) FUNGIZONE (APOTHECON) APPROVAL= AP YEAR= 1965 DISCONTINUED
NDA 050314 (pdf not found) INN (AMPHOTERICIN B) FUNGIZONE (APOTHECON) APPROVAL= AP YEAR= 1966 DISCONTINUED
NDA 060517 (pdf not found) INN (AMPHOTERICIN B) FUNGIZONE (APOTHECON) APPROVAL= AP YEAR= 1966 DISCONTINUED
NDA 050341 (pdf not found) INN (AMPHOTERICIN B) FUNGIZONE (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 1971 DISCONTINUED
NDA 062728 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (ABRAXIS PHARM) APPROVAL= AP YEAR= 1987 DISCONTINUED
NDA 063206 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (XGEN PHARMS) APPROVAL= AP YEAR= 1992
NDA 050724 (pdf not found) INN (AMPHOTERICIN B) ABELCET (LEADIANT BIOSCI INC) APPROVAL= AP YEAR= 1995 DISCONTINUED
NDA 064062 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (TEVA PARENTERAL) APPROVAL= AP YEAR= 1995 DISCONTINUED
NDA 050729 (pdf not found) INN (AMPHOTERICIN B) AMPHOTEC (ALKOPHARMA USA) APPROVAL= AP YEAR= 1996 DISCONTINUED
NDA 064141 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (ABBOTT) APPROVAL= AP YEAR= 1996 DISCONTINUED
NDA 050740 (pdf not found) INN (AMPHOTERICIN B) AMBISOME (ASTELLAS) APPROVAL= AP YEAR= 1997
NDA 212514 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (SPIL) APPROVAL= AP YEAR= 2021
NDA 214010 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (EUGIA PHARMA) APPROVAL= AP YEAR= 2022
NDA 212967 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (MYLAN LABS LTD) APPROVAL= AP YEAR= 2025
NDA 215354 (pdf not found) INN (AMPHOTERICIN B) AMPHOTERICIN B (AVET LIFESCIENCES) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL